Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by DavidRosenbergon Feb 08, 2023 7:27pm
431 Views
Post# 35275892

Why do small biotechs price spike up ?

Why do small biotechs price spike up ?
Small biotech companies' stocks can go up for several reasons, including:
 
Positive clinical trial results: Positive clinical trial results, especially for drugs in the late stages of development, can have a significant impact on a small biotech company's stock price.
 
Regulatory approvals: Regulatory approvals, such as FDA approval for a new drug, can also positively impact a small biotech company's stock price.
Partnerships and collaborations: Partnerships and collaborations with larger pharmaceutical companies or research institutions can provide funding and resources for a small biotech company, which can drive its stock price higher.
 
Market sentiment: The overall market sentiment towards the biotech sector, as well as specific trends in the industry, can also impact the stock price of small biotech companies.
 
Unusual trading activity: Small biotech companies are often subject to unusual trading activity, including short-term price spikes, as a result of news, rumors, or investor speculation.
 
It's important to note that the biotech sector is considered to be high risk and can be influenced by a variety of factors, including scientific, regulatory, and commercial risks. Therefore, investing in small biotech companies requires a thorough understanding of the company and its technology, as well as a carefully considered investment strategy
<< Previous
Bullboard Posts
Next >>